These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 32854452)

  • 1. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
    Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
    Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
    Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number.
    Singleton S; Baptista-Hon DT; Edelsten E; McCaughey KS; Camplisson E; Hales TG
    Br J Pharmacol; 2021 Apr; 178(8):1855-1868. PubMed ID: 33555037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological, and structural explorations of a series of μ-opioid receptor (MOR) agonists with high G protein signaling bias.
    Yang Y; Wang Y; Zuo A; Li C; Wang W; Jiang W; Zhang X; Che X; Zhang Y; Wu W; Cen X; Wang H; Tian J
    Eur J Med Chem; 2022 Jan; 228():113986. PubMed ID: 34802839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oliceridine in the treatment of moderate to severe acute pain.
    Eleswarpu SS; Habib AS
    Pain Manag; 2021 May; 11(3):237-248. PubMed ID: 33455450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
    Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
    ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Utilization of Mu-Opioid Receptor Biased Agonists: Oliceridine, an Opioid Analgesic with Reduced Adverse Effects.
    Urits I; Viswanath O; Orhurhu V; Gress K; Charipova K; Kaye AD; Ngo A
    Curr Pain Headache Rep; 2019 Mar; 23(5):31. PubMed ID: 30880365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biased Opioid Ligands.
    Faouzi A; Varga BR; Majumdar S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative pain.
    Azzam AAH; Lambert DG
    Expert Opin Drug Discov; 2022 Mar; 17(3):215-223. PubMed ID: 34817313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation.
    Zhao Z; Huang T; Li J
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ß-arrestin 2 germline knockout does not attenuate opioid respiratory depression.
    Bachmutsky I; Wei XP; Durand A; Yackle K
    Elife; 2021 May; 10():. PubMed ID: 34002697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics.
    Pedersen MF; Wróbel TM; Märcher-Rørsted E; Pedersen DS; Møller TC; Gabriele F; Pedersen H; Matosiuk D; Foster SR; Bouvier M; Bräuner-Osborne H
    Neuropharmacology; 2020 Apr; 166():107718. PubMed ID: 31351108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
    Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
    Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of μ receptors by SR-17018 through a distinctive mechanism.
    Singleton S; Dieterle C; Walker DJ; Runeberg T; Oswald AS; Rosenqvist G; Robertson L; McCarthy T; Sarkar S; Baptista-Hon D; Hales TG
    Neuropharmacology; 2024 Nov; 258():110093. PubMed ID: 39067665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents.
    Altarifi AA; David B; Muchhala KH; Blough BE; Akbarali H; Negus SS
    J Psychopharmacol; 2017 Jun; 31(6):730-739. PubMed ID: 28142305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window.
    Gillis A; Sreenivasan V; Christie MJ
    Mol Pharmacol; 2020 Oct; 98(4):410-424. PubMed ID: 32665252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The μ-opioid receptor-mediated G
    Xia J; Li X; Zhu H; Zhou X; Chen J; Li Q; Li S; Chu H; Dong M
    Eur J Pharmacol; 2024 Mar; 966():176333. PubMed ID: 38278466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers.
    Soergel DG; Subach RA; Burnham N; Lark MW; James IE; Sadler BM; Skobieranda F; Violin JD; Webster LR
    Pain; 2014 Sep; 155(9):1829-1835. PubMed ID: 24954166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.